Safety and effectiveness of transcervical radiofrequency ablation for uterine fibroids in patients with obesity: a retrospective cohort study
Archives of Gynecology and Obstetrics · 30.01.2026 · 313 (1)
DOI: 10.1007/s00404-025-08265-3 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 30.01.2026. Verfasst von Elvin Piriyev und 5 weiteren Autor:innen. Beteiligte Einrichtung: University Witten-Herdecke, Witten, Germany. piriyev.elvins@gmail.com. Hauptthemen laut MEDLINE: Obesity, Leiomyoma, Radiofrequency Ablation, Uterine Neoplasms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Private Universität Witten/Herdecke gGmbH.
Abstract (Originalsprache)
Key message Transcervical radiofrequency ablation is a low-risk, uterus-preserving option for symptomatic fibroids in women with obesity with significant improvement of bleeding disorder, including ≥ 40 kg/m 2 . Obesity should not preclude offering TFA.
Objective
To evaluate the safety and effectiveness of transcervical radiofrequency ablation (TFA) for uterine fibroids in women with obesity.
Methods
Retrospective multicenter cohort at two German Fibroid Centers. From 574 consecutive TFA cases, we included patients with BMI ≥ 30 kg/m 2 and ≥ 6-month follow-up; those with incomplete data were excluded. Fibroids were characterized by ultrasound. TFA (Sonata®) was performed per instructions for use. Outcomes were perioperative complications and patient-reported improvement in abnormal uterine bleeding (AUB).
Results
Sixty patients were analyzed (age 43.59 ± 6.52 years; BMI 35.72 ± 6.72 kg/m 2 ). Mean operative and ablation times were 33.65 and 9.91 min, respectively. One intraoperative bleeding event (1.7%) was controlled with a balloon catheter; no postoperative complications occurred. Mean follow-up was 17.08 months (6–54). Overall, 42/60 (70.0%) reported AUB improvement. By BMI category: 30–34.9 kg/m 2 25/39 (64.1%), 35–39.9 kg/m 2 5/7 (71.4%), ≥ 40 kg/m 2 12/14 (85.7%) (p = 0.3168). Considering the initial assessment, 48/60 (80.0%) improved; six later recurred, yielding 42/60 (70.0%) at last follow-up.
Conclusion
TFA showed a very low complication rate and clinically meaningful bleeding improvement in women with obesity, with comparable outcomes across BMI strata, including ≥ 40 kg/m 2 . Obesity is not a barrier to safe, effective TFA. Prospective, BMI-stratified studies with validated bleeding measures and objective endpoints are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Witten-Herdecke, Witten, Germany. piriyev.elvins@gmail.com.
- Department of Obstetrics and Gynecology, Academic Hospital Cologne Weyertal, Weyertal 76, 50931, Cologne, Germany. piriyev.elvins@gmail.com.
- Department of Obstetrics and Gynecology, Academic Hospital Cologne Weyertal, Weyertal 76, 50931, Cologne, Germany.
- University of Cologne, Cologne, Germany.
- Department of Gynecology and Obstetrics, Boeblingen Clinic, Hospital Sindelfingen-Böblingen, Böblingen, Germany.
- University Witten-Herdecke, Witten, Germany.
Förderung
- Private Universität Witten/Herdecke gGmbH
Zitieren
APA
Piriyev, E., Sadikova, M., Dieter, A., Schiermeier, S., Renner, S. P., & Römer, T. (2026). Safety and effectiveness of transcervical radiofrequency ablation for uterine fibroids in patients with obesity: a retrospective cohort study. Archives of Gynecology and Obstetrics, 313(1). https://doi.org/10.1007/s00404-025-08265-3
Vancouver
Piriyev E, Sadikova M, Dieter A, Schiermeier S, Renner SP, Römer T. Safety and effectiveness of transcervical radiofrequency ablation for uterine fibroids in patients with obesity: a retrospective cohort study. Archives of Gynecology and Obstetrics. 2026;313(1). doi:10.1007/s00404-025-08265-3
BibTeX
@article{Piriyev2026,
author = {Piriyev, Elvin and Sadikova, Mariam and Dieter, Angelika and Schiermeier, Sven and Renner, Stefan Peter and Römer, Thomas},
title = {Safety and effectiveness of transcervical radiofrequency ablation for uterine fibroids in patients with obesity: a retrospective cohort study},
journal = {Archives of Gynecology and Obstetrics},
year = {2026},
volume = {313},
number = {1},
doi = {10.1007/s00404-025-08265-3}
}
EUVIMED